Z2Sixty Ventures

Z2Sixty Ventures, at z2sixtyventures.com with LinkedIn and Crunchbase profiles, is a venture firm without disclosed stage, sector, or check size in the input record. The firm’s name and structure suggest a boutique investment brand, possibly with a thematic or generalist orientation rather than deep healthcare specialty. For healthcare AI founders, the practical assumption is that Z2Sixty is a candidate for participating checks or selective lead positions in early-stage software-defined companies with credible founding teams and clear early traction. Without an explicit healthcare program, founders should treat any conversation as opportunistic for the sector and confirm appetite before significant pitch effort. Check sizes for boutique funds of this profile typically span USD 250K to USD 1.5M, with selective follow-on. Geographic preference is unclear from the data and should be confirmed in a screening conversation. Healthcare AI verticals that fit this kind of investor include AI-native B2B SaaS targeting healthcare adjacencies, clinician productivity tools, ambient documentation, and consumer health products with capital-efficient growth narratives; capital-intensive biotech, regulated devices needing PMA pathways, and Series B-plus companies are not the right fit. Best entry path is a warm introduction through a portfolio founder if available, supplemented by a LinkedIn message to the managing partner with a tight one-paragraph teaser, traction summary, and explicit ask on participation rather than lead status. The first conversation should clarify fund status, active deployment, average check size, and recent healthcare investments before any deeper diligence. Founders should be ready to walk away politely if the firm cannot articulate a clear sector point of view; thinly documented funds reward efficient screening over hopeful pitching.